A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/00 (2006.01) A61K 31/425 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01) A61K 45/00 (2006.01)
Patent
CA 2305289
A method for the treatment of hyperglycaemia wherein plasma glucose levels in the range of from > 126 mg/dl to 140 mg/dl, which method comprises administering an effective nontoxic and pharmaceutically acceptable amount of an insulin sensitiser, to a mammal in need thereof.
Procédé de traitement de l'hyperglycémie pour laquelle le taux plasmique de glucose se situe entre ?126 mg/dl et 140 mg/dl. Ledit procédé consiste à administrer à un mammifère qui le nécessite une quantité efficace, non toxique et acceptable sur le plan pharmaceutique d'un sensibilisant à l'insuline.
Buckingham Robin Edwin
Smith Stephen Alistair
Gowling Lafleur Henderson Llp
Smithkline Beecham P.l.c.
LandOfFree
Use of thiazolidinediones for the treatment of hyperglycaemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thiazolidinediones for the treatment of hyperglycaemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thiazolidinediones for the treatment of hyperglycaemia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1705725